Optical coherence tomography tissue coverage and characterization at six months after implantation of bioresorbable scaffolds versus conventional everolimus eluting stents in the ISAR-Absorb MI trial
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1573-0743
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Optical coherence tomography tissue coverage and characterization at six months after implantation of bioresorbable scaffolds versus conventional everolimus eluting stents in the ISAR-Absorb MI trial ; volume:37 ; number:10 ; day:21 ; month:8 ; year:2021 ; pages:2815-2826 ; date:10.2021
The international journal of cardiovascular imaging ; 37, Heft 10 (21.8.2021), 2815-2826, 10.2021
- Creator
-
Rai, Himanshu
Alfonso, Fernando
Maeng, Michael
Bradaric, Christian
Wiebe, Jens
Cuesta, Javier
Christiansen, Evald Høj
Cassese, Salvatore
Hoppmann, Petra
Colleran, Roisin
Harzer, Fiona
Bresha, Jola
Nano, Nejva
Schneider, Simon
Laugwitz, Karl-Ludwig
Joner, Michael
Kastrati, Adnan
Byrne, Robert A.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s10554-021-02251-x
- URN
-
urn:nbn:de:101:1-2021122321163850951319
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:37 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Rai, Himanshu
- Alfonso, Fernando
- Maeng, Michael
- Bradaric, Christian
- Wiebe, Jens
- Cuesta, Javier
- Christiansen, Evald Høj
- Cassese, Salvatore
- Hoppmann, Petra
- Colleran, Roisin
- Harzer, Fiona
- Bresha, Jola
- Nano, Nejva
- Schneider, Simon
- Laugwitz, Karl-Ludwig
- Joner, Michael
- Kastrati, Adnan
- Byrne, Robert A.
- SpringerLink (Online service)
Other Objects (12)
Inzidenz und Prädiktoren der Stentthrombose in Bare-Metal-Stents und Drug-Eluting-Stents
Mechanical properties of the everolimus-eluting bioresorbable vascular scaffold compared to the metallic everolimus-eluting stent
Conformability in everolimus-eluting bioresorbable scaffolds compared with metal platform coronary stents in long lesions
Niedrigdosierte Paclitaxel-freisetzende Ballone gegen konventionelle Paclitaxel-freisetzende Ballone zur Therapie von Drug-Eluting-Stent- Restenosen bei Patienten mit koronarer Herzkrankheit
Comparison of everolimus-eluting and biolimus-eluting coronary stents with everolimus-eluting bioresorbable scaffold: study protocol of the randomized controlled EVERBIO II trial
Coronary Restenosis and Arterial Healing Following Drug-Eluting Stent Implantation – Time Course, Angiographic Metrics and Impact of Modifications in Polymer and Drug Coatings
Everolimus-eluting bioresorbable vascular scaffold in daily clinical practice: A single-centre experience
Five‐year follow‐up of patients who underwent everolimus‐eluting bioresorbable scaffold implantation
Everolimus eluting bioresorbable vascular scaffolds in patients with acute coronary syndromes: Two‐year results from the German‐Austrian ABSORB registry
Determinants of Clinical Outcomes Following Drug-Eluting Stent Implantation: Temporal Course, Mechanisms and Optical Characteristics of Stent Failure
Outcomes of 10,312 patients treated with everolimus‐eluting bioresorbable scaffolds during daily clinical practice – results from the European Absorb Consortium
Hybrid Coronary Percutaneous Treatment with Metallic Stents and Everolimus-Eluting Bioresorbable Vascular Scaffolds: 2-Years Results from the GABI-R Registry
Inzidenz und Prädiktoren der Stentthrombose in Bare-Metal-Stents und Drug-Eluting-Stents
Mechanical properties of the everolimus-eluting bioresorbable vascular scaffold compared to the metallic everolimus-eluting stent
Conformability in everolimus-eluting bioresorbable scaffolds compared with metal platform coronary stents in long lesions
Niedrigdosierte Paclitaxel-freisetzende Ballone gegen konventionelle Paclitaxel-freisetzende Ballone zur Therapie von Drug-Eluting-Stent- Restenosen bei Patienten mit koronarer Herzkrankheit
Comparison of everolimus-eluting and biolimus-eluting coronary stents with everolimus-eluting bioresorbable scaffold: study protocol of the randomized controlled EVERBIO II trial
Coronary Restenosis and Arterial Healing Following Drug-Eluting Stent Implantation – Time Course, Angiographic Metrics and Impact of Modifications in Polymer and Drug Coatings
Everolimus-eluting bioresorbable vascular scaffold in daily clinical practice: A single-centre experience
Five‐year follow‐up of patients who underwent everolimus‐eluting bioresorbable scaffold implantation
Everolimus eluting bioresorbable vascular scaffolds in patients with acute coronary syndromes: Two‐year results from the German‐Austrian ABSORB registry
Determinants of Clinical Outcomes Following Drug-Eluting Stent Implantation: Temporal Course, Mechanisms and Optical Characteristics of Stent Failure
Outcomes of 10,312 patients treated with everolimus‐eluting bioresorbable scaffolds during daily clinical practice – results from the European Absorb Consortium
Hybrid Coronary Percutaneous Treatment with Metallic Stents and Everolimus-Eluting Bioresorbable Vascular Scaffolds: 2-Years Results from the GABI-R Registry
Inzidenz und Prädiktoren der Stentthrombose in Bare-Metal-Stents und Drug-Eluting-Stents
Mechanical properties of the everolimus-eluting bioresorbable vascular scaffold compared to the metallic everolimus-eluting stent
Conformability in everolimus-eluting bioresorbable scaffolds compared with metal platform coronary stents in long lesions
Niedrigdosierte Paclitaxel-freisetzende Ballone gegen konventionelle Paclitaxel-freisetzende Ballone zur Therapie von Drug-Eluting-Stent- Restenosen bei Patienten mit koronarer Herzkrankheit
Comparison of everolimus-eluting and biolimus-eluting coronary stents with everolimus-eluting bioresorbable scaffold: study protocol of the randomized controlled EVERBIO II trial
Coronary Restenosis and Arterial Healing Following Drug-Eluting Stent Implantation – Time Course, Angiographic Metrics and Impact of Modifications in Polymer and Drug Coatings
Everolimus-eluting bioresorbable vascular scaffold in daily clinical practice: A single-centre experience
Five‐year follow‐up of patients who underwent everolimus‐eluting bioresorbable scaffold implantation
Everolimus eluting bioresorbable vascular scaffolds in patients with acute coronary syndromes: Two‐year results from the German‐Austrian ABSORB registry
Determinants of Clinical Outcomes Following Drug-Eluting Stent Implantation: Temporal Course, Mechanisms and Optical Characteristics of Stent Failure
Outcomes of 10,312 patients treated with everolimus‐eluting bioresorbable scaffolds during daily clinical practice – results from the European Absorb Consortium